1. Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor
    Takahito Hara et al, 2020, Biochemistry and Biophysics Reports CrossRef
  2. Targeting Tyrosine Kinases in Ovarian Cancer: Small Molecule Inhibitor and Monoclonal Antibody, Where Are We Now?
    Aimee Rendell et al, 2022, Biomedicines CrossRef
  3. TAM receptors Tyro3 and Mer as novel targets in colorectal cancer
    Robin Schmitz et al, 2016, Oncotarget CrossRef
  4. Targeting TAM to Tame Pancreatic Cancer
    Mitchell S. von Itzstein et al, 2020, Targeted Oncology CrossRef
  5. Intracellular catalase activity instead of glutathione level dominates the resistance of cells to reactive oxygen species
    Meng-Xin Zhao et al, 2019, Cell Stress and Chaperones CrossRef
  6. TAM Receptor Tyrosine Kinases in Cancer Drug Resistance
    Mikaella Vouri et al, 2017, Cancer Research CrossRef
  7. Endocytic trafficking of GAS6–AXL complexes is associated with sustained AKT activation
    Agata Poświata et al, 2022, Cellular and Molecular Life Sciences CrossRef
  8. Circ_0000467 Exerts an Oncogenic Role in Colorectal Cancer via miR-330-5p-Dependent Regulation of TYRO3
    Yubao Huang et al, 2022, Biochemical Genetics CrossRef
  9. TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma
    Kara M. Ruicci et al, 2020, Journal of Experimental & Clinical Cancer Research CrossRef
  10. Antitumour effects of a solid lipid nanoparticle loaded with gemcitabine and oxaliplatin on the viability, apoptosis, autophagy, and Hsp90 of ovarian cancer cells
    Ashwaq A. Al-Mutairi et al, 2022, Journal of Microencapsulation CrossRef
  11. TYRO3: A potential therapeutic target in cancer
    Pei-Ling Hsu et al, 2019, Experimental Biology and Medicine CrossRef
  12. Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment
    Kayla V. Myers et al, 2019, Molecular Cancer CrossRef
  13. TAM family proteins and therapy resistance
    Nellie K. McDaniel et al, 2020, Improving the Therapeutic Ratio in Head and Neck Cancer CrossRef
  14. A microRNA-7/growth arrest specific 6/TYRO3 axis regulates the growth and invasiveness of sorafenib-resistant cells in human hepatocellular carcinoma
    Tasnuva D. Kabir et al, 2018, Hepatology CrossRef
  15. Identification of Potentially Therapeutic Target Genes in Ovarian Cancer via Bioinformatic Approach
    Li Chengzhang et al, 2021, 2021 IEEE 9th International Conference on Bioinformatics and Computational Biology (ICBCB) CrossRef
  16. Tyro3 carboxyl terminal region confers stability and contains the autophosphorylation sites
    Hanshuang Shao et al, 2017, Biochemical and Biophysical Research Communications CrossRef
  17. Identification of signalling pathways activated by Tyro3 that promote cell survival, proliferation and invasiveness in human cancer cells
    Nour Al Kafri et al, 2021, Biochemistry and Biophysics Reports CrossRef
  18. LeMeDISCO is a computational method for large-scale prediction & molecular interpretation of disease comorbidity
    Courtney Astore et al, 2022, Communications Biology CrossRef
  19. The Emerging Role of TYRO3 as a Therapeutic Target in Cancer
    Sherri Smart et al, 2018, Cancers CrossRef
  20. G-749 Promotes Receptor Tyrosine Kinase TYRO3 Degradation and Induces Apoptosis in Both Colon Cancer Cell Lines and Xenograft Mouse Models
    Hae Dong Kim et al, 2021, Frontiers in Pharmacology CrossRef